Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $496.0700 (2.78%) ($496.0700 - $496.0700) on Wed. Mar. 17, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.58% (three month average) | RSI | 72 | Latest Price | $496.0700(2.78%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 1.2% a day on average for past five trading days. | Weekly Trend | REGN advances 3.1% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(51%) XLV(42%) DIA(36%) SPLV(36%) SPY(36%) | Factors Impacting REGN price | REGN will decline at least -0.79% in a week (0% probabilities). VIXM(-20%) UUP(-7%) VXX(-6%) TBT(-6%) IGOV(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.79% (StdDev 1.58%) | Hourly BBV | 1.8 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $480.85(3.17%) | 10 Day Moving Average | $472.61(4.96%) | 20 Day Moving Average | $466.51(6.34%) | To recent high | -9.6% | To recent low | 11.1% | Market Cap | $52.598b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |